Oncodna raised €19M in a Series B round in Feb 2020. The company is based in Gosselies, Belgium. Investors in the round: Swisscanto Private Equity, Vesalius Biocapital Partners. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €19M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
